Latest Documents


  • 20-September-2007

    English

    Bio-based Economy

    The focus at the OECD on industrial biotechnology is to identify the potential contribution of biotechnology to sustainable growth and development, and identify and appraise policy options for supply and demand side interventions that can drive efficient transition towards bio-based economy.

    Related Documents
  • 25-June-2007

    English

  • 14-June-2007

    English

    OECD Best Practice Guidelines for Biological Resource Centres

    This report presents the outcome of discussions held by the OECD member countries, together with a number of key partner countries, under the auspices of an expert Task Force established by the OECD Working Party on Biotechnology.

  • 31-October-2006

    English

    Creation and Governance of Human Genetic Research Databases

    Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.

  • 22-May-2006

    English, , 849kb

    OECD Biotechnology Statistics 2006

    The 2006 edition OECD Biotechnology Statistics includes data for 23 OECD countries and two observer countries, plus China (Shanghai), and takes a major step forward in improving the comparability of biotechnology indicators among countries.

  • 31-March-2006

    English

    Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

    This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

  • 27-February-2006

    English

  • 10-November-2005

    English

    OECD Workshop on Pharmacogenetics - Workshop Presentations

    Workshop Presentations

    Related Documents
  • 24-October-2005

    English

    Health Technologies and Decision Making

    While many countries have invested in the production of health technology assessment, evidence about its use in decision making is limited. This report analyses the barriers to, and facilitators of, evidence-based decision making in OECD health-care systems.

    Related Documents
  • 19-October-2005

    English

    Workshop on Pharmacogenetics: The Intersections between Innovation, Regulation and Health Delivery,

    This workshop brought together a wide range of stakeholders, including officials of regulatory agencies, representatives of relevant regional or international organizations, researchers, patients’ organizations and representative from industry.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>